Traduction de «events in patients with peripheral » (Néerlandais → Français) :

Berger JS, Kranz MJ, Kittelson JM et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease. A meta-analysis of randomized trials.
Fowkes FG, Price JF, Stewart MCW et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

2011: Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease.
Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric and abdominal aortic): Executive summary.

The FDA is reviewing Exjade safety information specifically on the risk of adverse events in patients with myelodysplastic syndrome (MDS) compared to patients without these conditions.
La FDA examine les informations concernant l’innocuité d’Exjade en particulier par rapport au risque d’effets secondaires chez les patients atteints du syndrome myélodysplasique (MDS) en comparaison des malades qui en sont indemnes.

Inhaled anticholinergics and risk of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bli Lancet 362 : 782-788(2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-bl Lancet 362 : 782-788(2003)